Tourmaline Bio Inc. (TRML) NASDAQ

$18.97 (1.19) (-5.88%)

Market Cap: $516.78M

As of 04/15/24 03:59 PM EDT. Market closed.

(TRML)

Tourmaline Bio Inc. (TRML)
NASDAQ

$18.97
(1.19) (-5.88%)

Market Cap: $516.78M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

talaris therapeutics is a late-clinical stage biotechnology company based in boston, ma and louisville, ky. talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. the company was founded on ... read more

talaris therapeutics is a late-clinical stage biotechnology company based in boston, ma and louisville, ky. talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. the company was founded on technology discovered and developed by dr. suzanne ildstad and operates its own cell processing facility in louisville. talaris is backed by leading life sciences investors blackstone life sciences, longitude capital and qiming venture partners usa. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
125
Address
.
PRICE CHART FOR TOURMALINE BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$20.18
Previous Close
$20.15
Days Range
$19.50 - $21.05
52 week range
$3.96 - $48.31
Volume
333,652
Avg. Volume (30 days)
656,300
Market Cap
$516.78M
Dividend Yield
-
P/E
-
Shares Outstanding
25,646,509
Open
$20.18
Previous Close
$20.15
Days Range
$19.50 - $21.05
52 week range
$3.96 - $48.31
Volume
333,652
Avg. Volume (30 days)
656,300
Market Cap
$516.78M
Dividend Yield
-
P/E
-
Shares Outstanding
25,646,509
FINANCIAL STATEMENTS FOR TOURMALINE BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TOURMALINE BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
MCDADE MARKDirectorJan 29, 2024 Buy$32.50100,0003,250,000448,431Jan 31, 2024, 04:26 PM
Kulkarni Sandeep ChidambarCEONov 17, 2023 Buy$16.994,00067,960729,735Nov 20, 2023, 06:15 PM
Thiara ParvinderDirectorNov 17, 2023 Buy$17.311,00017,31083,782Nov 20, 2023, 06:14 PM
Castelein CaleyDirectorOct 27, 2023 Buy$14.5515,800229,890516,519Oct 27, 2023, 05:43 PM
Castelein CaleyDirectorOct 25, 2023 Buy$12.074,20050,694500,719Oct 27, 2023, 05:43 PM
Kulkarni Sandeep ChidambarCEOOct 26, 2023 Buy$12.255,00061,250725,735Oct 26, 2023, 05:34 PM
Kulkarni Sandeep ChidambarCEOOct 24, 2023 Buy$10.684,65049,662720,735Oct 26, 2023, 05:34 PM
KANTOFF AARONDirectorOct 24, 2023 Buy$11.867,50088,95045,391Oct 26, 2023, 05:00 PM
Thiara ParvinderDirectorOct 25, 2023 Buy$12.122,00024,24082,782Oct 26, 2023, 04:46 PM
Thiara ParvinderDirectorOct 24, 2023 Buy$10.665,00053,30080,782Oct 26, 2023, 04:46 PM
Fenton Mary KayChief Financial OfficerJul 03, 2023 Option Exercise$3.0812,94639,87468,054Jul 06, 2023, 05:20 PM
Requadt ScottFormer Chief Executive OfficerJul 03, 2023 Option Exercise$3.0811,78636,301578,403Jul 06, 2023, 05:19 PM
Ildstad SuzanneDirectorJun 14, 2023 Sale$2.4912,94232,2443,771,392Jun 14, 2023, 06:58 PM
Ildstad SuzanneDirectorJun 13, 2023 Sale$2.5614,20836,3383,784,334Jun 14, 2023, 06:58 PM
Ildstad SuzanneDirectorJun 12, 2023 Sale$2.5916,87043,7253,798,542Jun 14, 2023, 06:58 PM
Ildstad SuzanneDirectorJun 09, 2023 Sale$2.4625,41962,6383,815,412Jun 09, 2023, 05:41 PM
Ildstad SuzanneDirectorJun 08, 2023 Sale$2.4840,642100,7723,840,831Jun 09, 2023, 05:41 PM
Ildstad SuzanneDirectorJun 07, 2023 Sale$2.3975,001179,0953,881,473Jun 09, 2023, 05:41 PM
Ildstad SuzanneDirectorJun 06, 2023 Sale$2.5325,54964,5962,756,474Jun 07, 2023, 06:24 PM
Ildstad SuzanneDirectorJun 05, 2023 Sale$2.527,84119,7552,782,023Jun 07, 2023, 06:24 PM
Ildstad SuzanneDirectorJun 02, 2023 Sale$2.5015,81839,6162,789,864Jun 05, 2023, 04:21 PM
Ildstad SuzanneDirectorJun 01, 2023 Sale$2.5615,71340,1772,805,682Jun 05, 2023, 04:21 PM
Ildstad SuzanneDirectorApr 21, 2023 Sale$2.3515,00435,2312,821,395Apr 25, 2023, 05:50 PM
Ildstad SuzanneDirectorApr 20, 2023 Sale$2.3346,990109,3132,836,399Apr 21, 2023, 07:57 AM
Ildstad SuzanneDirectorApr 19, 2023 Sale$2.1621,75347,0562,883,389Apr 21, 2023, 07:57 AM
Ildstad SuzanneDirectorApr 18, 2023 Sale$2.1549,211105,8042,905,142Apr 19, 2023, 09:22 AM
Ildstad SuzanneDirectorApr 17, 2023 Sale$2.1499,771213,5302,954,353Apr 19, 2023, 09:22 AM
Ildstad SuzanneDirectorMar 17, 2023 Sale$2.0610,43621,5433,054,124Apr 07, 2023, 04:25 PM
Ildstad SuzanneDirectorMar 03, 2023 Sale$2.066,80613,9923,064,560Apr 07, 2023, 04:23 PM
Ildstad SuzanneDirectorMar 01, 2023 Sale$2.0529593,071,366Apr 07, 2023, 04:21 PM
Ildstad SuzanneDirectorFeb 21, 2023 Sale$2.053,5007,1853,071,395Apr 07, 2023, 04:19 PM
Ildstad SuzanneDirectorFeb 16, 2023 Sale$2.062,9396,0403,078,507Apr 07, 2023, 04:17 PM
Ildstad SuzanneDirectorFeb 17, 2023 Sale$2.053,6127,4063,074,895Apr 07, 2023, 04:17 PM
Ildstad SuzanneDirectorMar 17, 2023 Sale$2.0610,43621,5433,054,124Mar 20, 2023, 04:36 PM
Ildstad SuzanneDirectorMar 03, 2023 Sale$2.066,80613,9923,064,560Mar 07, 2023, 04:58 PM
Ildstad SuzanneDirectorMar 01, 2023 Sale$2.0529593,071,366Mar 02, 2023, 05:26 PM
Ildstad SuzanneDirectorFeb 21, 2023 Sale$2.053,5007,1853,071,395Feb 23, 2023, 05:01 PM
Ildstad SuzanneDirectorFeb 17, 2023 Sale$2.053,6127,4063,074,895Feb 21, 2023, 11:16 AM
Ildstad SuzanneDirectorFeb 16, 2023 Sale$2.062,9396,0403,078,507Feb 21, 2023, 11:16 AM
Requadt ScottChief Executive OfficerDec 30, 2022 Option Exercise$0.8743590,193Feb 03, 2023, 05:01 PM
Nader FrancoisDirectorJul 21, 2022 Buy$3.7236,500135,780138,500Sep 13, 2022, 04:27 PM
Nader FrancoisDirectorJul 20, 2022 Buy$3.6252,000188,240102,000Sep 13, 2022, 04:27 PM
Nader FrancoisDirectorJul 19, 2022 Buy$3.5250,000176,00050,000Sep 13, 2022, 04:27 PM
Ildstad SuzanneChief Scientific OfficerAug 22, 2022 Sale$2.80525,0001,470,0003,081,446Aug 23, 2022, 07:43 PM
Requadt ScottChief Executive OfficerJul 29, 2022 Buy$4.2539,382167,374508,680Aug 02, 2022, 05:02 PM
Requadt ScottChief Executive OfficerJul 28, 2022 Buy$4.253,09013,133469,298Jul 28, 2022, 07:52 PM
Requadt ScottChief Executive OfficerJul 26, 2022 Buy$4.245,52823,439466,208Jul 28, 2022, 07:52 PM
Requadt ScottChief Executive OfficerJul 22, 2022 Buy$3.759,44435,412460,680Jul 26, 2022, 07:38 PM
Nader FrancoisDirectorJul 19, 2022 Buy$3.5250,000176,00050,000Jul 25, 2022, 07:35 PM
Nader FrancoisDirectorJul 21, 2022 Buy$3.7236,500135,780138,500Jul 25, 2022, 07:35 PM
Nader FrancoisDirectorJul 20, 2022 Buy$3.6252,000188,240102,000Jul 25, 2022, 07:35 PM
Requadt ScottChief Executive OfficerDec 31, 2021 Option Exercise$13.001,47019,110451,236Feb 02, 2022, 06:01 PM
Fenton Mary KayChief Financial OfficerDec 31, 2021 Option Exercise$13.001,00013,0001,000Feb 02, 2022, 06:00 PM
Zdanowski MichaelChief Technology OfficerDec 31, 2021 Option Exercise$13.001,47019,1101,470Feb 02, 2022, 06:00 PM
Clarus Lifesciences III, L.P.10% OwnerMay 11, 2021 Buy$17.0030,000510,0004,875,730May 14, 2021, 06:15 AM
Clarus Defined Exit I, L.P.10% OwnerMay 11, 2021 Buy$17.0030,000510,0004,875,730May 13, 2021, 09:59 PM
Agarwala SandipDirectorMay 11, 2021 Buy$17.00235,0003,995,0003,220,775May 11, 2021, 08:29 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
MCDADE MARKDirector01/29/20243,250,000
Kulkarni Sandeep ChidambarCEO11/17/202367,960
Thiara ParvinderDirector11/17/202317,310
Castelein CaleyDirector10/27/2023229,890
Castelein CaleyDirector10/25/202350,694
Kulkarni Sandeep ChidambarCEO10/26/202361,250
Kulkarni Sandeep ChidambarCEO10/24/202349,662
KANTOFF AARONDirector10/24/202388,950
Thiara ParvinderDirector10/25/202324,240
Thiara ParvinderDirector10/24/202353,300
Fenton Mary KayChief Financial Officer07/03/202339,874
Requadt ScottFormer Chief Executive Officer07/03/202336,301
Ildstad SuzanneDirector06/14/202332,244
Ildstad SuzanneDirector06/13/202336,338
Ildstad SuzanneDirector06/12/202343,725
Ildstad SuzanneDirector06/09/202362,638
Ildstad SuzanneDirector06/08/2023100,772
Ildstad SuzanneDirector06/07/2023179,095
Ildstad SuzanneDirector06/06/202364,596
Ildstad SuzanneDirector06/05/202319,755
Ildstad SuzanneDirector06/02/202339,616
Ildstad SuzanneDirector06/01/202340,177
Ildstad SuzanneDirector04/21/202335,231
Ildstad SuzanneDirector04/20/2023109,313
Ildstad SuzanneDirector04/19/202347,056
Ildstad SuzanneDirector04/18/2023105,804
Ildstad SuzanneDirector04/17/2023213,530
Ildstad SuzanneDirector03/17/202321,543
Ildstad SuzanneDirector03/03/202313,992
Ildstad SuzanneDirector03/01/202359
Ildstad SuzanneDirector02/21/20237,185
Ildstad SuzanneDirector02/16/20236,040
Ildstad SuzanneDirector02/17/20237,406
Ildstad SuzanneDirector03/17/202321,543
Ildstad SuzanneDirector03/03/202313,992
Ildstad SuzanneDirector03/01/202359
Ildstad SuzanneDirector02/21/20237,185
Ildstad SuzanneDirector02/17/20237,406
Ildstad SuzanneDirector02/16/20236,040
Requadt ScottChief Executive Officer12/30/20223
Nader FrancoisDirector07/21/2022135,780
Nader FrancoisDirector07/20/2022188,240
Nader FrancoisDirector07/19/2022176,000
Ildstad SuzanneChief Scientific Officer08/22/20221,470,000
Requadt ScottChief Executive Officer07/29/2022167,374
Requadt ScottChief Executive Officer07/28/202213,133
Requadt ScottChief Executive Officer07/26/202223,439
Requadt ScottChief Executive Officer07/22/202235,412
Nader FrancoisDirector07/19/2022176,000
Nader FrancoisDirector07/21/2022135,780
Nader FrancoisDirector07/20/2022188,240
Requadt ScottChief Executive Officer12/31/202119,110
Fenton Mary KayChief Financial Officer12/31/202113,000
Zdanowski MichaelChief Technology Officer12/31/202119,110
Clarus Lifesciences III, L.P.10% Owner05/11/2021510,000
Clarus Defined Exit I, L.P.10% Owner05/11/2021510,000
Agarwala SandipDirector05/11/20213,995,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TOURMALINE BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC591,8821.27%NewOther
BALYASNY ASSET MANAGEMENT L.P.344,1270.02%NewEvent Driven
BLACKROCK INC.272,3760.00018%NewOther
GEODE CAPITAL MANAGEMENT, LLC116,0290.00032%NewOther
RENAISSANCE TECHNOLOGIES LLC33,9760.00138%NewOther
CHANGE IN SHARES OUTSTANDING FOR TOURMALINE BIO INC
STOCK BUYBACKS FOR TOURMALINE BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
11.12%
1Q
12/31/2023
06/30/2023
12.56%
2Q
12/31/2023
03/31/2023
13.57%
3Q
12/31/2023
12/31/2022
14.26%
4Q
12/31/2023
09/30/2022
14.73%
5Q
12/31/2023
06/30/2022
15.53%
6Q
12/31/2023
03/31/2022
15.84%
7Q
12/31/2023
12/31/2021
62.98%
8Q
12/31/2023
09/30/2021
16.72%
9Q
12/31/2023
06/30/2021
73.42%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
11.12%
1Q
06/30/2023
12.56%
2Q
03/31/2023
13.57%
3Q
12/31/2022
14.26%
4Q
09/30/2022
14.73%
5Q
06/30/2022
15.53%
6Q
03/31/2022
15.84%
7Q
12/31/2021
62.98%
8Q
09/30/2021
16.72%
9Q
06/30/2021
73.42%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TOURMALINE BIO INC
LOADING...